Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01052818 2010-01-20

Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer

Unknown

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Clinical Trials

Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

IRSTB030

Change of Circulating Tumor Cells During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer.

CTCSFBC

Therapeutic Response Evaluation by CTC Expansion System

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy

Concordance Between Liquid and Tissue Biopsy

Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC

Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer

SMAC-2

Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device

Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients

Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP

Diagnostic Power Comparison Between VOCs and CTCs

ADNCHIR

CTCs

Circulating Tumor Cells in mCRC for Liver Resection

MSI in Circulatory DNA of Endometrial Cancer

CTC

CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System

Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in Immunotherapy

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

BMACR

CTCS

Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer

Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer

The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.

Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s)

Application Value of CTCs Detection for Advanced Gastric Cancer Patients

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring

Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy

Cultured Circulating Tumor Cells in Prostate and Other Cancers

Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer